4893 items matching your search terms.

Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome

Gao, B. Lindemann, K. Anderson, L. Fereday, S. Hung, J. Alsop, K. Tothill, R. W. Gebski, V. Kennedy, C. Balleine, R. L. Australian Ovarian Cancer Study, Group Harnett, P. R. Bowtell, D. D. DeFazio, A.
GYNECOLOGIC ONCOLOGY, 2016     DOI:10.1016/j.ygyno.2016.06.023

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies

Garber, S. T. Hashimoto, Y. Weathers, S. P. Xiu, J. Gatalica, Z. Verhaak, R. G. Zhou, S. Fuller, G. N. Khasraw, M. de Groot, J. Reddy, S. K. Spetzler, D. Heimberger, A. B.
NEURO ONCOL, 2016     DOI:10.1093/neuonc/now132

Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS

Geevasinga, N. Menon, P. Ng, K. Van Den Bos, M. Byth, K. Kiernan, M. C. Vucic, S.
AMYOTROPH LATERAL SCLER FRONTOTEMPORAL DEGENER, 2016     DOI:10.1080/21678421.2016.1188961

SIRFLOX: Differences in site of first progression between mFOLFOX6 ± bevacizumab versus mFOLFOX6 ± bev + selective internal radiation therapy in first-line patients with metastatic colorectal cancer

Gibbs, P. Heinemann, V. Sharma, N.K. Findlay, M.P.N. Ricke, J. Peeters, M. Perez, D Robinson, B.A. Strickland, A. Ferguson, T. Rodriguez, J. Kroening, H. Wolf, I. Ganju, V. Walpole, E.T. Boucher, E. Tichler, T.E. Gebski, V. Van Buskirk, M. Van Hazel, G.A.

Intraperitoneal chemotherapy in patients with optimally debulked ovarian cancer: the Westmead Hospital experience

Girgis, C. Brand, A. Wain, G. Hogg, R. Harnett, P. Lindemann, K.

MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial

Gormly, K. L. Coscia, C. Wells, T. Tebbutt, N. Harvey, J. A. Wilson, K. Schmoll, H. J. Price, T.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016     DOI:10.1111/1754-9485.12493

Overnight glucose and counter-regulatory hormone profiles in type 1 diabetes adults during closed loop insulin delivery vs sensor augmented pump with low glucose suspend

Graf, A Ward, G.M. Vogrin, S. Sharifi, A. Jayawardene, D. Horsburgh, J.C. Loh, M.M. Sundarajan, V. Jenkins, A.J. Colman, P.G. Bach, L. Kumareswaran, K. MacIsaac, R.J. Jones, T.W. O'Neal, D.N.

A prospective, longitudinal cohort study to investigate the impact of chemotherapy on cognition in testicular cancer

Grimison, P. Whitford, H.S. Kalinowski, P. Schembri, A. Toner, G. Stockler, M. Martin, A. Davis, I.D. Olver, I.N. ANZUP Cancer Trials Group,

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumors: updated analysis of an Australian multicenter phase II trial

Grimison, P.S. Stockler, M.R. Martin, A.J. Buizen, L Lawrence, N.J. Thomson, D.B. Gebski, V. Friedlander, M. Yeung, A. Gurney, H Rosenthal, M. Singhal, N Kichenadasse, G Wong, S.S. Vasey, P.A. Toner, G.C. Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Where have we gone wrong? Phase II trials do not inform the results of phase III trials in platinum resistant ovarian cancer

Grunewald, T. Tang, M. Chen, J. Lord, S. Friedlander, M. Lee, C.K.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study

Hague, W. E. Simes, J. Kirby, A. Keech, A. C. White, H. D. Hunt, D. Nestel, P. J. Colquhoun, D. M. Pater, H. Stewart, R. A. Sullivan, D. R. Thompson, P. L. West, M. Glasziou, P. P. Tonkin, A. M. Lipid study investigatorsdagger
CIRCULATION, 2016     DOI:10.1161/CIRCULATIONAHA.115.018580

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Hammel, P. Huguet, F. van Laethem, J. L. Goldstein, D. Glimelius, B. Artru, P. Borbath, I. Bouche, O. Shannon, J. Andre, T. Mineur, L. Chibaudel, B. Bonnetain, F. Louvet, C. L. A. P. Trial Group
JAMA, 2016     DOI:10.1001/jama.2016.4324

Pancreatic Islet Biology

Hardikar, A.
, 2016     DOI:10.1007/978-3-319-45307-1_1

Understanding diabetes and cardiovascular risk biomarkers in clinical samples—the FIELD trial and the DAMAGE study

Hardikar, A.A.
, 2016     DOI:10.5339/qfarc.2016.HBPP1183

The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study

He, E. Y. Hawkins, N. J. Mak, G. Roncolato, F. Goldstein, D. Liauw, W. Clingan, P. Chin, M. Ward, R. L.
ONCOLOGIST, 2016     DOI:10.1634/theoncologist.2015-0530